Insider trades
Wendall Wierenga, Director of Cytokinetics CYTK, has filed 0 purchases and 8 sales on the open market. The latest trade was on 25/07/15.
Wendall Wierenga
Director
- Company
- Cytokinetics CYTK
- First filing
- 23/01/04
- Trades
- 46 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- No record
- Last trade
- 25/07/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
CytokineticsCYTK | Open-market sale10b5-1 plan | 25/04/21 | 25/04/21 | 20,000 sh | $38.46 | $769,200 | −44.6% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/12/16 | 24/12/16 | 742 sh | $48.61 | $36,068.62 | −2.9% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/11/25 | 24/11/26 | 742 sh | $50.00 | $37,100 | −2.9% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 24/10/28 | 24/10/31 | 4,452 sh | $52.25 | $232,617 | −15.3% |
| Open-market sale10b5-1 plan | 23/12/27 | 23/12/27 | 10,000 sh2 trades | $73.60avg. | $736,000 | −34.9% | |
CytokineticsCYTK | Open-market sale10b5-1 plan | 23/08/21 | 23/08/21 | 6,020 sh | $32.02 | $192,760.4 | −24.9% |
CytokineticsCYTK | Open-market sale | 23/02/06 | 23/02/08 | 7,000 sh | $45.00 | $315,000 | −35.8% |